Zeitlin L - Search Results

1

Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate.

Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH. Munns CF, et al. Among authors: zeitlin l. J Bone Miner Res. 2004 Nov;19(11):1779-86. doi: 10.1359/JBMR.040814. Epub 2004 Aug 23. J Bone Miner Res. 2004. PMID: 15476577 Free article.

2

Modern approach to children with osteogenesis imperfecta.

Zeitlin L, Fassier F, Glorieux FH. Zeitlin L, et al. J Pediatr Orthop B. 2003 Mar;12(2):77-87. doi: 10.1097/01.bpb.0000049567.52224.fa. J Pediatr Orthop B. 2003. PMID: 12584489 Review.

3

Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism.

Rauch F, Plotkin H, Travers R, Zeitlin L, Glorieux FH. Rauch F, et al. Among authors: zeitlin l. J Clin Endocrinol Metab. 2003 Mar;88(3):986-92. doi: 10.1210/jc.2002-021371. J Clin Endocrinol Metab. 2003. PMID: 12629073

4

Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate therapy.

Rauch F, Plotkin H, Zeitlin L, Glorieux FH. Rauch F, et al. Among authors: zeitlin l. J Bone Miner Res. 2003 Apr;18(4):610-4. doi: 10.1359/jbmr.2003.18.4.610. J Bone Miner Res. 2003. PMID: 12674321 Free article.

5

Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.

Zeitlin L, Rauch F, Plotkin H, Glorieux FH. Zeitlin L, et al. Pediatrics. 2003 May;111(5 Pt 1):1030-6. doi: 10.1542/peds.111.5.1030. Pediatrics. 2003. PMID: 12728084

6

Effect of pamidronate treatment in children with polyostotic fibrous dysplasia of bone.

Plotkin H, Rauch F, Zeitlin L, Munns C, Travers R, Glorieux FH. Plotkin H, et al. Among authors: zeitlin l. J Clin Endocrinol Metab. 2003 Oct;88(10):4569-75. doi: 10.1210/jc.2003-030050. J Clin Endocrinol Metab. 2003. PMID: 14557424

7

The effect of cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta type V.

Zeitlin L, Rauch F, Travers R, Munns C, Glorieux FH. Zeitlin L, et al. Bone. 2006 Jan;38(1):13-20. doi: 10.1016/j.bone.2005.07.020. Epub 2005 Sep 12. Bone. 2006. PMID: 16162424

8

[Updates in osteogenesis imperfecta].

Zeitlin L, Wientroub S, Blumberg N. Zeitlin L, et al. Harefuah. 2003 Oct;142(10):688-93, 717. Harefuah. 2003. PMID: 14565069 Review. Hebrew.

9

PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization.

Kämpe AJ, Costantini A, Levy-Shraga Y, Zeitlin L, Roschger P, Taylan F, Lindstrand A, Paschalis EP, Gamsjaeger S, Raas-Rothschild A, Hövel M, Jiao H, Klaushofer K, Grasemann C, Mäkitie O. Kämpe AJ, et al. Among authors: zeitlin l. J Bone Miner Res. 2017 Dec;32(12):2394-2404. doi: 10.1002/jbmr.3233. Epub 2017 Sep 6. J Bone Miner Res. 2017. PMID: 28777485 Free article.

10

Cementless posterior spinal fusion for the treatment of OI patients with severe spine deformity-a case series.

Gurel R, Ovadia D, Lebel DE, Zeitlin L, Sigal A. Gurel R, et al. Among authors: zeitlin l. Eur Spine J. 2022 Jun;31(6):1566-1572. doi: 10.1007/s00586-022-07179-x. Epub 2022 Mar 23. Eur Spine J. 2022. PMID: 35322283

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page